BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3793588)

  • 21. [Familial canine pituitary-dependent hyperadrenocorticism in wirehaired Dachshunds].
    Stritzel S; Mischke R; Philipp U; Kleinschmidt S; Wohlsein P; Stock KF; Distl O
    Berl Munch Tierarztl Wochenschr; 2008; 121(9-10):349-58. PubMed ID: 18822606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hyperadrenocorticism in dogs: a survey of internists and dermatologists.
    Behrend EN; Kemppainen RJ; Clark TP; Salman MD; Peterson ME
    J Am Vet Med Assoc; 1999 Oct; 215(7):938-43. PubMed ID: 10511856
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyperadrenocorticism in cats: seven cases (1978-1987).
    Nelson RW; Feldman EC; Smith MC
    J Am Vet Med Assoc; 1988 Jul; 193(2):245-50. PubMed ID: 2841269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of growth hormone secretion in spontaneous canine hyperadrenocorticism and its reversal after treatment.
    Peterson ME; Altszuler N
    Am J Vet Res; 1981 Nov; 42(11):1881-3. PubMed ID: 7199880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
    Norman EJ; Thompson H; Mooney CT
    Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pheochromocytoma and hyperadrenocorticism in dogs: six cases (1982-1992).
    von Dehn BJ; Nelson RW; Feldman EC; Griffey SM
    J Am Vet Med Assoc; 1995 Aug; 207(3):322-4. PubMed ID: 7628933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gamma camera imaging of bilateral adrenocortical hyperplasia and adrenal tumors in the dog.
    Mulnix JA; Van den Brom WE; Lubberink AA; de Bruijne JJ; Rijnberk A
    Am J Vet Res; 1976 Dec; 37(12):1467-71. PubMed ID: 999071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progesterone secreting adrenal mass in a cat with clinical signs of hyperadrenocorticism.
    Boord M; Griffin C
    J Am Vet Med Assoc; 1999 Mar; 214(5):666-9. PubMed ID: 10088015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE; Feldman EC
    J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperadrenocorticism: treating dogs.
    Brown CG; Graves TK
    Compend Contin Educ Vet; 2007 Mar; 29(3):132-4, 136, 138 passim; quiz 144-5. PubMed ID: 17726933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-dexamethasone-suppressible, pituitary-dependent hyperadrenocorticism in a dog.
    Kemppainen RJ; Zenoble RD
    J Am Vet Med Assoc; 1985 Aug; 187(3):276-8. PubMed ID: 4030467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of risk factors for outcome associated with adrenal gland tumors with or without invasion of the caudal vena cava and treated via adrenalectomy in dogs: 86 cases (1993-2009).
    Barrera JS; Bernard F; Ehrhart EJ; Withrow SJ; Monnet E
    J Am Vet Med Assoc; 2013 Jun; 242(12):1715-21. PubMed ID: 23725435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical treatment of adrenocortical tumors: 21 cases (1990-1996).
    Anderson CR; Birchard SJ; Powers BE; Belandria GA; Kuntz CA; Withrow SJ
    J Am Anim Hosp Assoc; 2001; 37(1):93-7. PubMed ID: 11204483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1985 Jul; 187(1):49-53. PubMed ID: 2991177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's syndrome due to adrenocortical adenoma in a cat.
    Meijer JC; Lubberink AA; Gruys E
    Tijdschr Diergeneeskd; 1978 Oct; 103(20):1048-51. PubMed ID: 705743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinguishing dogs with functioning adrenocortical tumors from dogs with pituitary-dependent hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1983 Jul; 183(2):195-200. PubMed ID: 6309721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.